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Previous studies have shown that endocytic stimuli result in increased lysosomal
enzyme activity in the cultivated mouse peritoneal macrophage (1, 2). Inducers
may be interiorized by phagocytosis or pinocytosis and may be as simple as
L-amino acid polypeptides or as complex as serum or erythrocytes. A common
feature of inducers is their susceptibility to degradation within secondary
lysosomes. Indigestible substrates such as polystyrene particles or D-amino acid
polypeptides are ineffective inducers (2).
Although the mechanisms for lysosomal enzyme induction are incompletely
understood, it has been shown that colchicine inhibits enzyme induction by a
pinocytic stimulus (3). In view of previous suggestions that the abundant arrays
of microtubules within phagocytic cells are of importance in the promotion of
fusion among endosomes and lysosomes (4-9), it was of interest to examine the
possibility that colchicine inhibition oflysosomal enzyme induction was related
to effects ofthe drugon microtubules and to inhibitionofdegradationofingested
substances. The effects of colchicine on induction of acid phosphatase by
pinocytic and phagocytic stimuli and on degradation of endocytized materials
are evaluated in this report.
Materials and Methods
Animals.
￿
Pathogen-free male white mice, 25-30 g, of the NCS/PA strain (10) were used in all
experiments.
In Vitro Cultivation of Mononuclear Phagocytes. Cells were harvested from the peritoneal
cavities of unstimulated mice in heparinized, phosphate-buffered saline, pH 7.4, by techniques
previously described(1,2) . A 1.0 ml sample containing approximately 3 x 10° cells/ml in Medium 199
(Schwarz/Mann Diva, Becton, Dickinson & Co., Orangeburg, N. Y.) containing 20%heat-inactivated
newborn calf serum (NBCS)'(Grand Island Biological Co., Berkeley, Calif.) wasdispensedto each 12
x 35-mm Leighton tube, without cover slips, and was incubated for 1 h at 37°C, after which the
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adherent cells were washed twice with Medium 199 . The monolayers were then reincubated in
Medium 199 containing 30% NBCS and potassium penicillin G (1,000 U/ml) (Eli Lilly & Co .,
Indianapolis, Ind.) . Penicillin G was incorporated in fresh medium at all medium changes . When
experimental design required cultivation of the monolayers for longer than 24 h, the medium was
changed daily . Unless otherwise specified, all cultivation medium consisted of Medium 199 with 30%
NBCS and penicillin G (1,000 U/ml) .
Inhibitors .
￿
Colchicine (Sigma Chemical Co ., St . Louis, Mo .) was made up as 10-' or 10-'Mstock
solutions in phosphate-buffered saline, pH 7 .4, and stored frozen as 0.5-ml aliquots . Lumicolchicine,
a mixture of photoisomers of colchicine (11), was kindly prepared by Leslie Wilson, Department of
Pharmacology, Stanford University School of Medicine, by ultraviolet irradiation of an ethanol
solution of colchicine . Aftervacuum evaporation of the alcohol, the residue was reconstituted to a
10-3M solution in phosphate-buffered saline, pH 5.0, and stored at -20°C in 0.5-ml portions . Purity
of the preparation wasconfirmedby its absorption spectrum and lack oftubulin-binding properties .
Cycloheximide (Sigma Chemical Co .) was used as an inhibitor of protein synthesis . Solutionswere
freshly made each day .
Acid Phosphatase Assay .
￿
At the time of harvest of cells which were to be analyzed for enzyme
content the medium was decanted from duplicate Leighton tubes and the monolayers rinsed three
times with normal saline . Each tube then received 0.5 ml normal saline andwas stored at -20°C until
the time of assay . Cells were separated from the glass by subjecting the tubes to four freeze-thaw
cycles and scraping with a rubber policeman . Assay for acid phosphatase activity based on the
hydrolysis of a-naphthol acid phosphate using methods previously described (12) was performed on
0.1-ml aliquots . Enzyme levels were determined by measuring increase in absorbance at 545 nm in a
Gilford spectrophotometer (Gilford Instrument Laboratories, Inc., Oberlin, Ohio) .
All enzyme activities are corrected for cell protein and are expressed as nanomoles inorganic
phosphate released x minutes- ' x milligrams -' cell protein. This expression of activity will be
considered to represent acid phosphatase specific activity .
ProteinAssay.
￿
Protein content wasdetermined by the method ofLowry (13) using crystalline egg
white lysozyme as the standard .
Sucrose Uptake . Macrophages which had been allowed to mature in 30% NBCS for 24 h were
rinsed with Medium 199and incubated in freshMedium 199 containing 50, 30, or 1% NBCS, with or
without 10-eM colchicine or 10- bM lumicolchicine . Afteran additional 2h incubation, 0.05ml of 0.6
M sucrose containing 5.0 uCi ['H]sucrose (glucose-D-[1- 3H]fructose, sp act 4.79 Ci/mmol, New
England Nuclear, Boston, Mass .) was added to each tube. Duplicate samples from all experimental
groups were harvested at 2, 4, and 6 h after addition of the radiolabel . All tubes were rinsed four times
with 5-ml vol ofMedium 199 containing 0.03M sucrose andthe monolayers dissolved in 0.5 ml of 0.1
NNaOH . Aliquots of the hydrolysate were assayed for protein as described above . 0.25-ml aliquots
were transferred to scintillation vials and mixed with 10 ml scintillation fluid (5.76 ml toluene, 0.24
ml Liquifluor [New England Nuclear], and 4.0 ml ethylene glycol monomethyl ether) . A Mark II
liquid scintillation counter (Nuclear-Chicago Corp ., Des Plaines, Ill .) was used to assay for
radioactivity .
[3H]Sucrose Degradation .
￿
Macrophage monolayers that had been allowed to mature for 24 h in
Medium 199 containing 30% NBCS received fresh Medium 199-30% NBCS with the addition of 4.5
,uCi/ml [3H]sucrose with 0.03M unlabeled carrier sucrose. After an additional 24 h of incubation at
37°C, sucrose-containing medium was removed and the monolayers rinsed four times with Medium
199 . Fresh Medium 199-30% NBCS was added to control tubes and colchicine (10-6-10-3 M) was
added to remaining tubes . After incubation for an additional 2 h at 37°C, duplicate tubes from
control and colchicine groups were harvested and designated as 0 time samples . Invertase
(melibiase-free, Nutritional Biochemicals Corp ., Cleveland, Ohio) in varying concentrations wasthen
added and duplicate samples from both control and colchicine-treated cells were harvested hourly
during the subsequent 6h. Control and colchicine-treated cells to which invertasewas not added were
also harvested .
Monolayers were harvested by rinsing four times with normal saline (5 ml) after which0.5 ml of0.5
NNaOH was added to digest cell protein . Aliquots were assayed for protein and for radioactivity as
described above .
Bacterial Uptake and Degradation .
￿
Staphylococcus albus and Bacillus subtilis were used for
studies of bacterial uptake and degradation . A single colony of S. albus or 0.01 ml of a spore1032
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suspension of B. subtilis (approximately 108 spores/ml) was inoculated into amedium composed of48
ml leucine assay medium (Difco Laboratories, Detroit, Mich.), 2 ml Medium 199, and 0.2 mCi
['H]leucine (L-[4,5-'H,N]leucine, sp act 33 .6 Ci/mmol, New England Nuclear) . The bacteria were
incubated for 18-24 h at 37°C in ashaking water bath, after which the bacteria were sedimented by
centrifugation at 12,000 g for 10 min. The sediment waswashed 4times with sterile phosphate-buff-
ered saline (PBS), pH 7.4, aliquots were taken for estimation of colony count by plate-counting
technique, and the bacterial suspension was killed by autoclaving for 15 min. After sterilization, the
suspension was again rinsed four times with PBS. After repeated rinsings, less than 5% of the total
radiolabel wasfound in the TCA-soluble fraction of the bacterial suspension.
24-h old monolayers were used in all experiments involving bacteria. Colchicine (10-e M) was
added to the cells in the treatment group 2 h before addition of bacteria and was present for the
duration of the experiments. The bacterial inoculum was in the range of 2-4 x 108 colony-forming
units (CFU)/ml, or approximately 20-40 CFU/mononuclear phagocyte . For evaluation of uptake,
duplicate tubes from control and colchicine groups were harvested at hourly intervals after the
addition of particles. At the time of harvest, the medium wasdecanted and frozen, andthe tubes were
rinsed four times with 5-ml portions of normal saline . Each tube wasfrozen with afinal aliquot of0.5
ml normal saline. Monolayers were removed from the glass and the cells disrupted by freeze-thaw
treatment as described above. 0.25-ml aliquots of the cell suspension and 0.5-ml aliquots of the
medium were precipitated with 7% TCA at 0-4°C. 0.25-ml aliquots of the TCA-soluble fraction were
transferred to scintillation vials. The precipitates were washed twice with 7% TCA, dissolved in 0.5 N
NaOH and transferred to scintillation vials. Scintillation fluid and counting for radioactivity were as
described above. Accumulation of radiolabel in the TCA-precipitable fraction of the monolayer was
considered to represent ingestion .
For evaluation of degradation, monolayers were allowed to ingest the bacteria for 1 or 2 h.
Uningested bacteria were removedby aspiration of medium andrinsing four times with Medium 199.
Fresh medium was added and incubation was continued. Duplicate tubes from both experimental
and control groups were harvested at intervals during the following 24 h and processed in the same
manner as in evaluation of ingestion . Conversion of the radiolabel from that associated with the
TCA-precipitable monolayer protein to that associated with the TCA-soluble fraction ofthe medium
was considered to represent degradation of bacterial protein (14).
There was less intertube variation in total radiolabel counts in the experiments involving S. albus
than in those involving B. subtilis. For this reason, the degradation of S. albus is expressed as
percentage of the radiolabel in the TCA-precipitable fraction of the monolayer at the end of the
phagocytic pulse which had been converted to TCA-soluble label in the medium at each indicated
time, while the degradation of B. subtilis is expressed as percentage of the total counts in the tube
which are associated with the TCA-soluble fraction of the medium at each indicated time.
Protein Synthesis. The incorporation of ['H]leucine into TCA-precipitable cell protein by
macrophage monolayers was used to estimate protein synthesis. Serum-containing medium was
rinsed from 24-h old monolayers with three washes of leucine-free Medium 199, and the cells were
cultivated for 2 h in leucine-free Medium 199 without added serum. Inhibitors were added at the
beginning of cultivation in leucine-free medium . 5.0 uCi ['H]leucine was added to each tube and
cultivation at 37°C was continued. Duplicate samples in each experimental group were harvested at
60 min. Preliminary experiments had indicated that, under the conditions employed, uptake of
['H]leucine waslinear for at least 60 minin all groups. Themedium was removed andthe monolayers
were rinsed four times with normal saline, covered with 0.5 ml normal saline, and frozen . Cells were
harvested by freeze-thaw cycles and scraping, and aliquots precipitated in 7% TCA, as described
above. Only the radioactivity in the TCA-precipitable fraction of the cell proteinwas assayed. Uptake
of ['H ]leucine was corrected for total cell protein.
Amino Acid Uptake.
￿
Uptake of thenonassimilable amino acid, ['H]alpha aminoisobutyric acid,
([3H]ABA) using slight modifications of published techniques (15), was used as an index of amino
acid uptake by macrophages .
24-h old monolayers were rinsed with Earle's balanced salt solution (BSS) (Microbiological
Associates, Inc., Bethesda, Md.), inhibitors were added, andthe monolayers were again incubated at
37°C for approximately 90 min in BSS. 5.0 WCi ['H]ABA (sp act 2 .5 Ci/mmol) (ICN, Isotope and
Nuclear Division, Irvine, Calif.) was added and duplicate tubes were harvested from each
experimental group at 0, 5, 10, 15, and 30 min after addition of radiolabel . Uptake of radiolabel wasEDWARD L. PESANTI AND STANTON G. AXLINE
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halted and free label removed by rapidly rinsing the tubes four times with 12-ml vol of iced normal
saline. Monolayers were then digested with 0.5 ml of 0.5 N NaOH. 0.25 ml of the final solution was
assayed for radioactivity as described above. Uptake of [1H]ABA is expressed as nanomoles ['H ]ABA
per microgram cell protein.
Morphology. When detailed microscopic examination of monolayers was desired and for
photomicrography, preparation of monolayers differed from the method described above only in that
cover slips were used in the Leighton tubes. The medium was decanted and cells were fixed with
glutaraldehyde at 4°C.
Data Analysis.
￿
With few exceptions, which are clearly indicated, all data are expressed as the
mean t SE of duplicate values from three or more experiments. Statistical inferences are derived for
Student's t test for unpaired samples. Only P < 0.05 (two-tailed) was considered to be statistically
significant. Straight lines, when shown, represent least mean squares analyses of the data.
Results
Cell Morphology . Addition of colchicine at concentrations of 10 -8 M or
greater caused macrophages cultivated in Medium 199 with 30% NBCS to
become rounded within 2 h. Over the following 6-8 h, the cells began to assume
bizarre forms as previously described by Bhisey and Freed (16, 17). By 24 h all
cells were clearly abnormal. The fraction of cells with obviously abnormal form at
24 h after addition of colchicine increased as the concentration of colchicine in
the medium was increased from 10-7.5 to 10 -8 M, with approximately one-half
the cells rendered abnormal by 10-7M colchicine . Increasing the concentration of
the drug in the range of 10 -B-10-3 M did not further alter the appearance of
individual cells. However, the initial rounding seemed to occurmore rapidlywith
higher concentrations of the drug, an effect that has been observed by others (16),
and there was increased detachment of cells from the glass.
Morphological changes produced by cultivating macrophages in 10-e M
colchicine for24-48 h were fullyreversible . Within 24 hafter removal ofthe drug,
colchicine-treated cells were indistinguishable from controls. Lumicolchicine, a
mixture of photoisomers of colchicine which retains the less specific membrane
effects of colchicine while lacking its tubulin-binding properties (18), did not
alter the appearance of macrophages even when used at concentrations as high as
10 -4.5 M.
Acid Phosphatase.
￿
Although previously noted (3), the effects of colchicine on
acid phosphatase induction have not been well characterized. The rise in specific
activity of acid phosphatase resulting from cultivation of macrophages in
medium containing 30% NBCS, which occurred between 24 and 72 h of cell age
after explant, and the complete inhibition of this rise by 10-8 M colchicine are
illustrated in Fig. 1.
The inhibitory effect of colchicine on acid phosphatase induction by pinocyto-
sis paralleled the action of the drug on alterations in cell shape. Maximal
inhibition of acid phosphatase induction was attained at concentrations of
colchicine (10-e M) which caused abnormal shapes to develop in all the cultured
cells. Further increases in colchicine concentration did not significantly enhance
inhibitory activity. Furthermore, at concentrations below 10 -'. 5 M, colchicine
was ineffective as an inhibitor of lysosomal enzyme induction by pinocytosis,
while concentrations intermediate betweenthe extremes resulted in intermediate
inhibition of acid phosphatase induction (Fig. 2) .1034 COLCHICINE EFFECTS ON LYSOSOMAL ENZYME INDUCTION
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￿
Temporal change in acid phosphatase specific activity for control (") andcolchicine-
treated (10-°M) (O) macrophages cultivated in 30% NBCS . Mean t SE of duplicate values
from six experiments .
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￿
Dose-response curve for inhibition of acid phosphatase inductionby colchicine.Mean
t SE of duplicate values from three experiments .
To further examine the possibility that both morphological changes and
inhibition of enzyme induction were related to colchicine's action on mi-
crotubules, macrophages cultivated in 30% serum as above were exposed to
lumicolchicine in concentrations ranging from 10-8 to 10-4 M. No effect of this
drug on lysosomal enzyme induction could be demonstrated, and acid phospha-
tase levels were indistinguishable from those in controls after cultivation of the
cells in 1-3 x 10 -5M lumicolchicine for 48 h (93.8 =E 4.7% of control levels) .
Because inhibitors of pinocytosis also inhibit lysosomal enzyme induction
resulting from cultivation of macrophages in serum (3), the effects of colchicineEDWARD L. PESANTI AND STANTON G. AXLINE
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on pinocytosis, as measured by uptake of sucrose (19, 20), were evaluated.
Accumulation ofsucrose 6 h afteraddition ofthetritiated sugar and theinfluence
of varying serum concentrations, colchicine (10-e M), and lumicolchicine (10-5
M) are illustrated in Fig. 3. Colchicine significantly retarded sucrose uptake in
medium containing 30% and 50% NBCS, but did not significantly inhibit the
ability of cells cultivated in 1% NBCS to accumulate the sugar. In contrast,
lumicolchicine did not significantly retard sucrose uptake in 50% NBCS. Also
illustrated in Fig. 3 is the effect ofserum concentration on sucrose uptake . In the
absence of colchicine, sucrose uptake increased in a proportional and nearly
linear fashion with serum concentrations over the range from 1-50% NBCS. In
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Uptake of
￿
['H ]sucrose in 0.03 M unlabeled sucrose; effect of varying serum
concentrations for control ("), 10- e M colchicine-treated (O), and 10- "M lumicolchicine-
treated (A) macrophages. The slopes of the regression lines for colchicine-treated and control
macrophages differ significantly (P < 0.05). Mean f SE of duplicate values from three experi-
ments.
the presence of colchicine (10- e M), sucrose uptake in 50% NBCS was not
significantly different than that in 1% NBCS. These data suggest that colchicine
is a potent inhibitor of pinocytosis by the cultivated macrophage.
Ifthe inhibition of pinocytosis were the primary or sole mechanism underlying
colchicine inhibition of acid phosphatase induction, the drug would be expected
to have no effect on lysosomal enzyme induction by a phagocytic stimulus. The
effect of colchicine on acid phosphatase 'induction by ingested sheep erythrocytes
was therefore examined.
Control cells that hadbeen allowed to mature for 24 hwere cultured an additional 24 hin Medium
199 and30%NBCS. Another group of cells was cultivated in Medium 199 and 1% NBCS after rinsing
the monolayers with Medium 199. A phagocytic stimulus was provided by addition of aldehyde-
treated sheep erythrocytes (SRBC) (Difco Laboratories, Detroit, Mich.) (3 x 108/ml) to the 24-h old
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cells. The phagocytic stimulus was terminated after 1 h by aspiration of the medium and rinsing of
the monolayers three times with Medium 199, after which the appropriate medium with 30% or 1%
NBCS was added. One group of cells that was to be exposed to 1% NBCS and colchicine (10' M)
received the combination immediately after termination of the phagocytic pulse. Another group
exposed to 1% serum received colchicine 2 h before the addition of SRBC. Colchicine was added to
cells which were cultivated without SRBC at the time of the medium change. The time at which
SRBC were added was considered to be time zero and experiments were terminated 24 h later.
Fig. 4 illustrates that both 30% NBCS and SRBC with 1% NBCS induced acid
phosphatase activity in the 24-h period of cultivation, while 1% NBCS was
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￿
Effect of colchicine on acid phosphatase (AP) induction by phagocytic and pinocytic
stimuli. Cells cultivated in 1% or 30%NBCS, with or without SRBC, with or without colchicine
(10- ' M). (A), 30% NBCS; (B), 30% NBCS-colchicine; (C), 30% NBCS plus SRBC**-colchi-
cine; (D), 1% NBCS; (E), 1% NBCS plus SRBC** ; (F), 1% NBCS-colchicine; and (G), 1%
NBCS plus SRBC**-colchicine; and(H), 1% NBCS plus SRBC*-colchicine. SRBC were added
either 1 h before (*) or 2 h after (**) colchicine.
AP specific activity 48 h - AP specific activity 24 h
AP specific activity 24 h
ineffective . Colchicine (10- s M) completely inhibited the rise in acid phospha-
tase activity whether the inducer was a phaocytic (B), phagocytic (G, H), or a
combination of both (C) stimuli. Moreover, the inhibition of acid phosphatase
induction by colchicine was complete whether the ingestion of SRBC occurred
before (G) or after (H) the cells were treated with colchicine.EDWARD L. PESANTI AND STANTON G. AXLINE
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These results indicate that colchicine effectively inhibited the induction of
acid phosphatase activity by both phagocytic and pinocytic stimuli, and that the
inhibition results from interference in the processes responsible for induction at
some step that occurs after particles have been interiorized . Because the
morphological effects of colchicine were found to be reversible within 24 h after
the drug was removed from the culture medium it was of interest to determine if
the inhibitory effect on acid phosphatase induction was similarly reversible .
Colchicine (10-e M) was added to macrophages 3-4 h after explantation in order that colchicine
could be removed from the cells at a time during which control cells were still rapidly increasing in
enzyme content . Four experimental groups were utilized : no colchicine, colchicine present for 96 h,
colchicine removed at 24 h, and colchicine removed at 48 h . All cells were cultivated in Medium 199
with 30% NBCS .
Inhibitory effects of 24 or 48 h of colchicine exposure on acid phosphatase
induction by cultivation in 30%NBCS were reversed within 24 h afterremoval of
the drug (Fig . 5) . Although the acid phosphatase specific activity in cells after
removal of colchicine was at all time points significantly lower than control
levels, the activities were significantly higher than those in cells with continuing
exposure to the drug . The rate of increase ofenzyme levels in cells released from
the inhibition of colchicine approximated that in control cells.
Protein Synthesis .
￿
Colchicine is not generally thought to be an inhibitor of
protein synthesis (21) . However, there are data suggesting that, in some cell lines
(22), the drug may interfere with protein synthesis, and there is no specific
mention concerning its effects on this function in macrophages. For this reason
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￿
Reversal of inhibition of acid phosphatase induction afterremoval of colchicine (10- e
M) . Temporal change in acid phosphatase specific activity for control cells ("), cells exposed
to colchicine for duration ofexperiment (O), cellsexposed to colchicine from 4 to 24 h (4), and
cells exposed to colchicine from 4 to 48 h (0). Mean f SE of duplicate values from four
experiments .1038
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the possibility that colchicine's inhibition of lysosomal enzyme induction might
be mediated by an inhibitory effect on protein synthesis was examined.
Colchicine (>_ 10-s M) inhibited the accumulation of [3H]leucine into
TCA-precipitable macrophage protein by 25% compared with controls under the
conditions used in these experiments (Fig . 6) . In contrast, lumicolchicine had no
effect on protein synthesis. Additionally, the effect of colchicine was not
enhanced by increasing the concentration of colchicine beyond 10 -8 M. The
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FIG. 6. Inhibition of incorporation of ['H]leucine into TCA-precipitable cell protein by
cycloheximide ("), colchicine (A), and lumicolchicine (O).
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degree of inhibition of protein synthesis produced by colchicine was comparable
to that produced by very low concentrations of cycloheximide (10-8-10-' M) .
These concentrations of cycloheximide did not alter acid phosphatase induction
resulting from cultivation of macrophages in 30% NBCS for 48 h (107 zE 6.5% of
control levels), although 10 - s M cycloheximide (70% inhibition of protein
synthesis) did inhibit enzyme induction.
Since, under certain circumstances, colchicine has been shownto inhibit lysine
transport in rabbit phagocytes (23), the measured inhibition of incorporation of
[3H]leucine into TCA-precipitable protein could have been a reflection of
inhibition of amino acid uptake rather than a specific effect on protein synthesis.
Therefore, uptake of the nonassimilable amino acid [3H]ABA was examined to
discriminate drug-induced alterations in uptake from effects on cellular protein
synthesis (15) .
Colchicine (10- s M) retarded the uptake of [3H]ABA, while lumicolchicine
exerted no effect (Fig. 7) . Moreover, the uptake of [3H]ABA was linear for the
initial 30-min time period for control and lumicolchicine-treated cells but was
clearly nonlinear for colchicine-treated cells.
Degradation of Intracellular Sucrose by Exogenous Invertase. The role ofc
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FIG. 7.
￿
Uptake of ['H]aminoisobutyric acid by macrophages. Effect of 10-6 M colchicine (O)
(three experiments) and 10 -' M lumicolchicine (") (two experiments) compared with control
(") (three experiments) . Mean t SE (colchicine, control) or mean f range (lumicolchicine) of
duplicate values.
microtubules in the fusion of lysosomes with newly ingested pinosomes was
evaluated by measuring the effect of colchicine on degradation of intracellular
sucrose by added invertase. Since macrophages lack enzymes with invertase
activity, nonhydrolyzed sucrose accumulates within pinolysosomes which swell,
presumably secondary to the accumulation of water across an osmotic gradient.
Invertase, added to the medium, is also interiorized by pinocytosis. These
pinocytic vesicles would be expected to fuse with the previously formed
secondary lysosomes; when the latter contain sucrose, the sugar is hydrolyzed to
its diffusible monosaccharide constituents (19) .
Macrophages which had been allowed to accumulate [1H]sucrose with 0.03 M
unlabeled carrier sucrose for 24 h contained large numbers of phase lucent
vacuoles. When the medium was changed to sucrose-free medium, the cell-
associated radiolabel remained quite stable, such that approximately 10% was
lost over a 6 h period . Addition of invertase (375 pg/ml) resulted in accelerated
loss of radiolabel as the sucrose was hydrolyzed to glucose and [3H]fructose, and
the latter diffused into the medium . The loss of radiolabel proceeded linearly
during the 6-h experimental period, at the end of which invertase-treated cells
had approximately 25% the intracellular sucrose concentration of control cells
incubated without invertase. At all time points, loss of radiolabel was unaffected1040 COLCHICINE EFFECTS ON LYSOSOMAL ENZYME INDUCTION
by pretreatment of cells with colchicine (10- s M) for 2 h before addition of
invertase. Increasing the concentration of colchicine to 10-3 M was similarly
withouteffect, as was increasing the duration of exposure of the cells to colchicine
before addition of invertase (4 or 24 h) . To examine the possibility that the
concentration of invertase in the medium was so excessive as to mask any effect
of colchicine on sucrose hydrolysis, a wide range of concentrations of invertase,
from 0.6 pg/ml through 375 gg/ml was studied. Loss of radiolabel from the
monolayers was directly proportional to the concentration of added invertase
(Fig . S), and was unaffected by pretreatment of the cells with colchicine (10- s
M) .
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Dose-response relationship of varying concentrations of exogenous invertase on loss of
['H]sucrose from macrophages. Comparison of control (") with cells treated with 10-° M
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Bacterial Degradation. Although no effect of colchicine on degradation of
sucrose by exogenous invertase, and by inference no effect of colchicine on fusion
among pinosomes and secondary lysosomes, was demonstrated, it remained
possible that, with a different substrate, inhibition could be demonstrated . To
further examine this possibility, the degradation of radiolabeled bacteria by
control and colchicine-treated macrophages was evaluated. Data for uptake and
degradation of [3H]leucine-labeled S. albus and B. subtilis are presented.
Colchicine (10-s M) exerted no measurable effect on uptake of either bacterial
species. This was evident if only the radiolabel present in undegraded bacterial
protein (TCA-precipitable monolayer fraction) was considered (Fig. 9 a) or if the
products of early degradation (TCA-soluble medium fraction) were added (Fig . 9
b) . Similarly, the drug did not alter intracellular degradation of radiolabeledd
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Lack of colchicine (10-°M) effect on uptake anddegradation of [1H]Ieucine-labeled
heat-killed bacteria. Uptake of S . albus (a) normalized for total monolayer protein and of B.
subtilis (b)by control (") and colchicine-treated (O) macrophages . Degradation of ingestedS.
albus (c) andB. subtilis (d)by control (open bars) and colchicine-treated (cross-hatched bars)
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bacterial protein of either S. albus or B. subtilis by mouse peritoneal macro-
phages cultivated in vitro (Figs . 9 c and 9 d) .
Discussion
These studies were performed to evaluate the hypothesis that microtubules are of
functional significance in induction of lysosomal enzymes and in intracellular
degradation of materials endocytosed by phagocytic cells . Colchicine was chosen
as an agent with known ability to disrupt microtubules through its abilityto bind
with and prevent polymerization of tubulin (24) . The shape and spontaneous
motility of macrophages are altered by the drug (16, 17) and the action of migra-
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tion inhibitory factor on guinea pig macrophages is inhibited by concentrations
as low as 10' M (25) .
In addition, colchicine has been shown to inhibit the in vitro induction of
certain lysosomal enzymes in the maturing mouse macrophage (3). Axline and
Cohn (2) have shown that only materials that are digestible by the peritoneal
macrophage are effective inducers of lysosomal enzymes and others have
suggested that microtubules are necessary for the fusion of lysosomes with
endosomeswhich must precede intracellular digestion of ingested materials (4-9,
26, 27). If microtubules do play such a role, colchicine could inhibit lysosomal
enzyme induction by inhibiting lysosomal fusion and rendering ordinarily
digestible materials indigestible .
Our results indicate that colchicine reversibly inhibits induction of acid
phosphatase resulting from either a phagocytic or pinocytic stimulus. This effect
on enzyme induction was evident at the same concentrations of colchicine which
caused morphologic alterations indicative of microtubular depolymerization (16,
28) in macrophages.
Additional evidence obtained through use of lumicolchicine suggests that the factor
underlying the above phenomena was disruption of microtubules (18). Photoinactivation
of colchicine yields lumicolchicine which, lacking tubulin-binding properties, is incapable
of depolymerizing microtubules and is without antimitotic (29) and anti-inflammatory
(30) effects, although it retains colchicine's effects on membrane transport systems (18) .
In our experiments, lumicolchicine, at concentrations 100 times greater than effective
molar concentrations of colchicine, did not alter cell morphology or inhibit lysosomal
enzyme induction.
Deuterium oxidehasbeen shownin othersystems to stabilize the microtubular network
(31) and to antagonize the action of colchicine on histamine secretion by leukocytes (27,
32). In separate experiments not outlined above, exposure of cells to deuterium oxide at
final concentrations up to 54% did not antagonize colchicine's effects on cell form or
lysosomal enzyme induction in the macrophage.
It is unlikely that inhibition of pinocytosis is the primary basis for colchicine's
inhibition of lysosomal enzyme induction. Cultivation of peritoneal macrophages
in serum-poor medium, which does not provide a pinocytic stimulus, does not
induce lysosomal enzymes. However, the lack of enzyme induction is readily
overcome by phagocytic stimuli (2). A brief phagocytic pulse (of aldehyde-
treated SRBC in our experiments) resulted in lysosomal enzyme induction
comparable to that found secondary to cultivation in medium containing 30%
serum. Inhibition of induction by colchicine differed from lack of induction
resultingfrom cultivation in serum-poor medium in that the phagocytic pulse did
not overcome colchicine's inhibition of enzyme induction.
Although inhibition of RNA synthesis by colchicine has been tentatively ad-
vanced as a mechanism for inhibition of lysosomal enzyme induction (3), the
drug is not now thought. to effect RNA synthesis. It does inhibit purine and
pyrimidine uptake, but this uptake is not essential for normal nucleotide syn-
thesis in mammalian cells (18).
Similarly, colchicine's inhibition of [gH]leucine incorporation into TCA-EDWARD L. PESANTI AND STANTON G. AXLINE
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precipitable material by macrophages seems unlikely to account for the drug's
effects on acid phosphatase induction. Inhibitors of protein synthesis are known
to inhibit lysosomal enzyme induction (3) and cycloheximide was shown to in-
hibit acid phosphatase induction in our experiments. However, only when the
concentration of cycloheximide was increased to levels which inhibited protein
synthesis by 70% (10-8 M) did cycloheximide inhibit induction of acid phos-
phatase by pinocytic stimuli. Colchicine did not inhibit ['H]leucine incorpora-
tion by more than 25%, but completely inhibited acid phosphatase induction
resulting from cultivation of macrophages in 30% NBCS between 24 and 96 h
after explant.
On the basis of the inhibition of [9H]ABA uptake by colchicine, we conclude
that the drug inhibits amino acid uptake in this cell type and do not postulate a
separate effect ofthe drug on protein synthesis per se. Colchicine hasbeen shown
to inhibit lysine incorporation by rabbit phagocytes under certain conditions
(23); others (18) have found no effect of the drug on amino acid uptake in a
variety of cell types.
The lack of effect of lumicolchicine on uptake of [3H]leucine and [3H]ABA
suggests that amino acid uptake by the mouse peritoneal macrophage may
require participation of intact microtubules. Alternatively, just as colchicine and
lumicolchicine exhibit differences in binding to mammalian cell membranes (33,
34), these two agents could produce differential effects on certain membrane-
mediated functions.
Although colchicine effects on acid phosphatase changes in vitro may be
related to an interaction ofthe drug with microtubules it is unlikely that these
effects are explicable by inhibition of fusion among lysosomes and endosomes
and consequent inhibition of degradation ofendocytized substances. No effect of
colchicine on degradation of intracellular sucrose by exogenous invertase or on
degradation of bacteria ingested by macrophage monolayers could be shown.
However, it remains possible that when intact microtubules are present they are
of functional significance in the promotion of fusion of endosomes with
lysosomes. It would then be necessary to assume that the churning, ameboid
movements which have been described in colchicine-treated macrophages (16,
17) have increased random contact among subcellular particles, thus negating
the expected inhibitory effect of colchicine.
Several groups have attempted to define the role of microtubules in lysosomal fusion in
phagocytic cells (6-9, 17, 27, 35-37). Weissmann et al. (6) have noted that protein
degradation was retarded by treatment of macrophages with colchicine. Other authors
have based their conclusions on the loss of lysosomal enzymes into the medium which
occurs consequent to phagocytosis of inert particles (7), which follows attempted
phagocytosis ofbiologically active materials that are too large to be interiorized (8, 9, 35),
or which results from treatment of phagocytes with cytochalasin B followed by a
phagocytic stimulus (8, 27). Different authors have concluded from these enzyme release
studies that at concentrations as low as 10-' Mcolchicine inhibited lysosomal fusion (7, 8,
27), that the drug was effective at high (10' M) but not at low (10-8 M) concentrations
(9), or that the drug had no effect at any concentration through 10-3 M (35).
Cinephotomicrographic studies have shown that, although the patternsof movement of1044 COLCHICINE EFFECTS ON LYSOSOMAL ENZYME INDUCTION
both the macrophage and its intracellular granules were altered by treatment with
colchicine, no visible inhibition of fusion of endocytic vacuoles with lysosomes was evident
(17) . Polymorphonuclear leukocytes pretreated with colchicine degraded radiolabeled
thyroxine in a manner indistinguishable from controls (36) . In addition, Stossel et al .
noted that colchicine did not diminish the formation of phagolysosomes by polymor-
phonuclear leukocytes in their system in which phagolysosomes containing buoyant inert
particles are separated from other subcellular particles and unfused lysosomes by density
gradient centrifugation (37) .
Thus, we were able to confirm and further define the inhibitory effect of
colchicine on acid phosphatase induction in the mouse peritoneal macrophage . In
addition, data presented in this paper provide further support for previous
observations (2) that interiorization of substrate is necessary but not sufficient to
promote lysosomal enzyme induction . That an effective lysosomal enzyme
inducer must be susceptible to intracellular degradation has been demonstrated
(2) and our data imply a further requirement for intact microtubules in acid
hydrolase induction by endocytic stimuli .
The site at which colchicine acts to inhibit lysosomal enzyme induction cannot
yet be determined . However, recent speculations by Verity (38) andEhrlich et al .
(21) may be relevant . Verity has postulated that invasion of the nucleoplasm by
lysosomes is required for lysosomal enzyme induction in certain hormone-sensi-
tive cell lines (38) . Such an unusual migration of cytoplasmic particles should
require direction and microtubules would be obvious candidates for this role .
Ehrlich et al . have demonstrated inhibition of collagen secretion and synthesis by
colchicine in embryonic cranial bone cells and suggest that microtubular
disruption blocks egress of secretory protein from the Golgi apparatus, with
consequent inhibition of synthesis (21) . In the macrophage, microtubular
disruption could result in a reduced rate at which newly formed primary
lysosomes exit to the cytoplasm from the Golgi region .
Summary
The effects of colchicine on lysosomal fusion and lysosomal enzyme induction in
the cultivated mouse peritoneal macrophage have been examined . Colchicine
(10-6 M), but not lumicolchicine, inhibited lysosomal enzyme induction by both
phagocytic and pinocytic stimuli . In addition, the drug significantly retarded
pinocytic uptake of [3H]sucrose and transport of the amino acids [3H]alpha
aminoisobutyric acid and L- [3H]leucine . In contrast, lumicolchicine had no effect
on pinocytosis or amino acid transport . Thus, a role for intact microtubules in
lysosomal enzyme induction, pinocytosis, and amino acid uptake in these cells is
suggested . That colchicine inhibited lysosomal enzyme induction by phagocytic
stimuli under conditions in which pinocytosis contributed little to the enzyme
rise indicated that inhibition of pinocytosis was unlikely to account for colchicine
effects on lysosomal enzyme induction .
Effects of colchicine on degradation of phagocytized and pinocytized sub-
strates were examined to determine if intact microtubules are required for fusion
among lysosomes, pinosomes, and phagosomes . Colchicine did not alter the rate
of intracellular digestion of radiolabeled bacteria by the cultivated macrophage .
Similarly, it had no effect on enzymatic hydrolysis of intracellular [3H]sucroseEDWARD L . PESANTI AND STANTON G . AXLINE
resulting from uptake of exogenous invertase . The finding that colchicine had no
effect on the functional consequences of fusion of lysosomes with endosomes
suggests that intact microtubules are not required for fusion among these
constituents of the vacuolar apparatus .
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